Best Seller

Recombinant Human CLEC9a Fc Chimera Protein, CF

R&D Systems | Catalog # 6049-CL

R&D Systems
Loading...

Key Product Details

  • R&D Systems NS0-derived Recombinant Human CLEC9a Fc Chimera Protein (6049-CL)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

NS0

Accession Number

Structure / Form

Disulfide-linked homodimer

Applications

Bioactivity
Loading...

Product Specifications

Source

Mouse myeloma cell line, NS0-derived human CLEC9a protein
Met-Asp
Human IgG1
(Pro100-Lys330)
IEGR Human CLEC9a
(Lys57-Val241)
Accession # Q6UXN8
N-terminus C-terminus

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Met

Predicted Molecular Mass

47.8 kDa (monomer)

SDS-PAGE

55-65 kDa, reducing conditions

Activity

Measured by flow cytometry for its ability to bind a ligand expressed in FasL-treated mouse B cells. Sancho, D. et al. (2009) Nature 458:899.
At 100 ng/mL, >50% of necrotic cells bind to Recombinant Human CLEC9a.

Reviewed Applications

Read 1 review rated 5 using 6049-CL in the following applications:

Formulation, Preparation, and Storage

6049-CL
Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution

Reconstitute at 200 μg/mL in PBS.


Loading...
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: CLEC9a

CLEC9A (C-type lectin domain family 9 member A), also known as DNGR-1, is a type II transmembrane glycoprotein member of the C-type lectin superfamily (1). Mature mouse CLEC9A consists of a 35 amino acid (aa) cytoplasmic domain with an ITAM-like motif, a 21 aa transmembrane segment, and a 185 extracellular domain (ECD) that contains a stalk region and one C-type lectin domain (CTLD) (2-4). Within the ECD, human CLEC9A shares 57% aa sequence identity with mouse and rat CLEC9A. Although the CTLD of CLEC9A structurally resembles that of other C-type lectins, it lacks the conserved residues that typically mediate calcium and carbohydrate binding. CLEC9A is expressed as a disulfide-linked homodimer of approximately 50 kDa N-glycosylated subunits (2, 4). Human CLEC9A expression is restricted to a subpopulation of BDCA-3+ conventional dendritic cells (cDC) and CD16- monocytes (2-5). BDCA-3+ cDC are analagous to mouse CD8+ cDC which are specialized in antigenic cross-presentation in complex with MHC class I molecules (6). In mouse, CLEC9A is additionally expressed on plasmacytoid dendritic cells (3, 4). CLEC9A ligation enhances antigen uptake and processing, leading to presentation on MHC class I and cytotoxic T cell (CTL) priming (2-5, 7). Its recognition of filamentous actin in dead cells is important for triggering an immune response to necrotic cell debris (8-10). CLEC9A is also required for the presentation of viral proteins and the subsequent CTL-mediated killing of virus-infected cells (11, 12). CLEC9A signaling triggers activation of the tyrosine kinase Syk (2, 8).

References

  1. Kerrigan, A.M. and G.D. Brown (2010) Immunol. Rev. 234:335.
  2. Huysamen, C. et al. (2008) J. Biol. Chem. 283:16693.
  3. Caminschi, I. et al. (2008) Blood 112:3264.
  4. Sancho, D. et al. (2008) J. Clin. Invest. 118:2098.
  5. Schreibelt, G. et al. (2012) Blood 119:2284.
  6. Dudziak, D. et al. (2007) Science 315:107.
  7. Poulin, L.F. et al. (2010) J. Exp. Med. 207:1261.
  8. Sancho, D. et al. (2009) Nature 458:899.
  9. Ahrens, S. et al. (2012) Immunity 36:635.
  10. Zhang, J.-G. et al. (2012) Immunity 36:646.
  11. Iborra, S. et al. (2012) J. Clin. Invest. 122:1628.
  12. Zelenay, S. et al. (2012) J. Clin. Invest. 122:1615.

    Long Name

    C-type Lectin-like Receptor 9

    Alternate Names

    CD370, DNGR1

    Entrez Gene IDs

    283420 (Human); 232414 (Mouse)

    Gene Symbol

    CLEC9A

    UniProt

    Additional CLEC9a Products

    Product Documents for Recombinant Human CLEC9a Fc Chimera Protein, CF

    Certificate of Analysis

    To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

    Note: Certificate of Analysis not available for kit components.

    Product Specific Notices for Recombinant Human CLEC9a Fc Chimera Protein, CF

    For research use only

    Citations for Recombinant Human CLEC9a Fc Chimera Protein, CF

    Customer Reviews for Recombinant Human CLEC9a Fc Chimera Protein, CF (1)

    5 out of 5
    1 Customer Rating
    5 Stars
    100%
    4 Stars
    0%
    3 Stars
    0%
    2 Stars
    0%
    1 Stars
    0%

    Have you used Recombinant Human CLEC9a Fc Chimera Protein, CF?

    Submit a review and receive an Amazon gift card!

    $25/€18/£15/$25CAN/¥2500 Yen for a review with an image

    $10/€7/£6/$10CAN/¥1110 Yen for a review without an image

    Submit a review
    Amazon Gift Card
    Showing  1 - 11 review Showing All
    Filter By:
    • Recombinant Human CLEC9a Fc Chimera Protein, CF
      Name: Anonymous
      Application: ELISA
      Verified Customer | Posted 03/30/2025

    There are no reviews that match your criteria.

    Showing  1 - 11 review Showing All

    FAQs

    No product specific FAQs exist for this product.

    View all FAQs for Proteins and Enzymes